| The global obesity pandemic: shaped by global drivers and local environments BA Swinburn, G Sacks, KD Hall, K McPherson, DT Finegood, ML Moodie, ... The lancet 378 (9793), 804-814, 2011 | 6319 | 2011 |
| Assessment of Insulin Sensitivity in Vivo RN Bergman, DT Finegood, M Ader Endocrine reviews 6 (1), 45-86, 1985 | 1486 | 1985 |
| Changing the future of obesity: science, policy, and action SL Gortmaker, BA Swinburn, D Levy, R Carter, PL Mabry, DT Finegood, ... The Lancet 378 (9793), 838-847, 2011 | 1314 | 2011 |
| The need for a complex systems model of evidence for public health H Rutter, N Savona, K Glonti, J Bibby, S Cummins, DT Finegood, ... The lancet 390 (10112), 2602-2604, 2017 | 1164 | 2017 |
| A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome RS Legro, D Finegood, A Dunaif The Journal of Clinical Endocrinology & Metabolism 83 (8), 2694-2698, 1998 | 1144 | 1998 |
| Grand challenges in chronic non-communicable diseases AS Daar, PA Singer, D Leah Persad, SK Pramming, DR Matthews, ... Nature 450 (7169), 494-496, 2007 | 930 | 2007 |
| The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome A Dunaif, D Scott, D Finegood, B Quintana, R Whitcomb The Journal of Clinical Endocrinology & Metabolism 81 (9), 3299-3306, 1996 | 884 | 1996 |
| Dynamics of β-cell mass in the growing rat pancreas: estimation with a simple mathematical model DT Finegood, L Scaglia, S Bonner-Weir Diabetes 44 (3), 249-256, 1995 | 860 | 1995 |
| Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome A Dunaif, DT Finegood The Journal of Clinical Endocrinology & Metabolism 81 (3), 942-947, 1996 | 689 | 1996 |
| Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates DT Finegood, RN Bergman, M Vranic Diabetes 36 (8), 914-924, 1987 | 686 | 1987 |
| Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat L Scaglia, CJ Cahill, DT Finegood, S Bonner-Weir Endocrinology 138 (4), 1736-1741, 1997 | 521 | 1997 |
| β-cell mass dynamics in Zucker diabetic fatty rats: rosiglitazone prevents the rise in net cell death DT Finegood, MD McArthur, D Kojwang, MJ Thomas, BG Topp, T Leonard, ... Diabetes 50 (5), 1021-1029, 2001 | 499 | 2001 |
| The evolution of β‐cell dysfunction and insulin resistance in type 2 diabetes RN Bergman, DT Finegood, SE Kahn European journal of clinical investigation 32, 35-45, 2002 | 431 | 2002 |
| A model of β-cell mass, insulin, and glucose kinetics: pathways to diabetes B Topp, K Promislow, G Devries, RM Miura, D T FINEGOOD Journal of theoretical biology 206 (4), 605-619, 2000 | 397 | 2000 |
| Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog G Toffolo, RN Bergman, DT Finegood, CR Bowden, C Cobelli Diabetes 29 (12), 979-990, 1980 | 376 | 1980 |
| Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? JD Trudeau, JP Dutz, E Arany, DJ Hill, WE Fieldus, DT Finegood Diabetes 49 (1), 1-7, 2000 | 365 | 2000 |
| Implications of the foresight obesity system map for solutions to childhood obesity DT Finegood, TDN Merth, H Rutter Obesity 18 (S1), S13-S16, 2010 | 325 | 2010 |
| Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and β-cell … JA Pospisilik, SG Stafford, HU Demuth, R Brownsey, W Parkhouse, ... Diabetes 51 (4), 943-950, 2002 | 309 | 2002 |
| Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood JD Trudeau, C Kelly-Smith, CB Verchere, JF Elliott, JP Dutz, DT Finegood, ... The Journal of clinical investigation 111 (2), 217-223, 2003 | 301 | 2003 |
| Defects in insulin secretion and action in women with a history of gestational diabetes EA Ryan, SI Imes, D Liu, R McManus, DT Finegood, KS Polonsky, J Sturis Diabetes 44 (5), 506-512, 1995 | 259 | 1995 |